.RESEARCH STUDY FEATURE.06 August 2024.
A huge randomized regulated trial along with cisgender ladies highlights the obstacles of faithfulness to a daily oral preexposure prevention routine as well as shows that twice-yearly injection of lenacapavir may maintain successful HIV avoidance amounts over 6 months.